-+ 0.00%
-+ 0.00%
-+ 0.00%

Moderna's 2025-2026 Spikevax Formula Gains FDA Approval for High-Risk Groups and Seniors, Reinforcing Strong Immune Response Against LP.8.1 Variant

Reuters·09/16/2025 10:11:30

Please log in to view news